11 – 20 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
A Novel Assay for Antibody-Dependent Cell-Mediated Cytotoxicity against HIV-1-or SIV-Infected Cells Reveals Incomplete Overlap with Antibodies Measured by Neutralization and Binding Assays
(
- Contribution to journal › Article
-
Mark
IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: A possible new treatment?
(
- Contribution to journal › Article
-
Mark
Prevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase.
(
- Contribution to journal › Article
-
Mark
IgG glycan hydrolysis by EndoS diminishes the pro-inflammatory properties of immune complexes from patients with SLE - a possible new treatment?
(
- Contribution to journal › Published meeting abstract
- 2011
-
Mark
Up-Regulation of A1M/α(1)-Microglobulin in Skin by Heme and Reactive Oxygen Species Gives Protection from Oxidative Damage.
(
- Contribution to journal › Article
- 2010
-
Mark
The IgG specific endoglycosidase EndoS inhibits both cellular and complement mediated autoimmune hemolysis.
(
- Contribution to journal › Article
-
Mark
Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease.
(
- Contribution to journal › Article
- 2009
-
Mark
Sugar-free antibodies--the bacterial solution to autoimmunity?
2009) 6th International Congress on Autoimmunity In Annals of the New York Academy of Sciences 1173. p.664-669(
- Contribution to journal › Article
- 2008
-
Mark
EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity
(
- Contribution to journal › Article
-
Mark
Enzymatically Generated Low Carbohydrate Antibodies as a Novel Treatment for Autoimmune Disease
(
- Contribution to journal › Published meeting abstract